Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118179863 | 11817986 | 3 | F | 200907 | 20160808 | 20151210 | 20160830 | PER | US-JNJFOC-20151119059 | JANSSEN | 27.98 | YR | A | M | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118179863 | 11817986 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | VARYING DOSE 0.25 MG AND 0.50 MG | U | U | 0 | UNSPECIFIED | |||||||
| 118179863 | 11817986 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | .5 | MG | UNSPECIFIED | ||||||
| 118179863 | 11817986 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | UNSPECIFIED | ||||||||
| 118179863 | 11817986 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | UNSPECIFIED | ||||||||
| 118179863 | 11817986 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | .5 | MG | UNSPECIFIED | ||||||
| 118179863 | 11817986 | 6 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | VARYING DOSE 0.25 MG AND 0.50 MG | U | U | 0 | UNSPECIFIED | |||||||
| 118179863 | 11817986 | 7 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | VARYING DOSE 0.25 MG AND 0.50 MG | U | U | 0 | UNSPECIFIED | |||||||
| 118179863 | 11817986 | 8 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | .5 | MG | UNSPECIFIED | ||||||
| 118179863 | 11817986 | 9 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 20272 | UNSPECIFIED | ||||||||
| 118179863 | 11817986 | 10 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118179863 | 11817986 | 1 | Mood swings |
| 118179863 | 11817986 | 2 | Mood swings |
| 118179863 | 11817986 | 3 | Mood swings |
| 118179863 | 11817986 | 4 | Drug therapy |
| 118179863 | 11817986 | 5 | Drug therapy |
| 118179863 | 11817986 | 6 | Drug therapy |
| 118179863 | 11817986 | 7 | Bipolar disorder |
| 118179863 | 11817986 | 8 | Bipolar disorder |
| 118179863 | 11817986 | 9 | Bipolar disorder |
| 118179863 | 11817986 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118179863 | 11817986 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118179863 | 11817986 | Gynaecomastia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118179863 | 11817986 | 1 | 200903 | 200904 | 0 | |
| 118179863 | 11817986 | 2 | 200907 | 201004 | 0 | |
| 118179863 | 11817986 | 3 | 201008 | 201102 | 0 | |
| 118179863 | 11817986 | 4 | 201008 | 201102 | 0 | |
| 118179863 | 11817986 | 5 | 200907 | 201004 | 0 | |
| 118179863 | 11817986 | 6 | 200903 | 200904 | 0 | |
| 118179863 | 11817986 | 7 | 200903 | 200904 | 0 | |
| 118179863 | 11817986 | 8 | 200907 | 201004 | 0 | |
| 118179863 | 11817986 | 9 | 201008 | 201102 | 0 |